ABSTRACT:We investigated the effects of a single course of antenatal betamethasone on cognition-and anxiety-related behavior and synaptophysin and microtubule-associated protein 2 (MAP2) immunoreactivity in the adult rat hippocampus. On d 20 of gestation, pregnant rats were injected with either 1) 170 g/kg body weight of betamethasone ("clinically equivalent dose," equivalent to 12 mg twice, 24 h apart); 2) half this dose; or 3) vehicle. Cognition-and anxiety-related behavior of the offspring was analyzed at an age of 5 mo using the Morris water maze, object recognition task, and open field test. Subsequently, synaptophysin and MAP2 immunoreactivity were measured in the hippocampus. We report no detrimental effects of antenatal betamethasone on cognition-and anxiety-related behavior and synaptophysin immunoreactivity in the adult rat. On the other hand, MAP2 immunoreactivity was decreased by betamethasone in males, suggesting a permanent impairment in the hippocampus. Interestingly, the lower dose appears to have less influence in terms of growth restriction, known to be associated with an increased risk of disease in adulthood. Further research might elucidate whether the betamethasone effect on hippocampal neurons persists later in life and could affect the aging process increasing the risk for neuropathology of the adult. A ntenatal glucocorticoids are widely used to prevent respiratory distress syndrome in case of threat of preterm delivery (1). Although beneficial for lung maturation, this treatment causes a wide range of side effects in humans, including a reduction in weight and head circumference at birth (2), and in impairment in both circulating glucocorticoid bioactivity (3) and cortisol response to stressors (4). Animal studies showed that antenatal glucocorticoids affect the hypothalamic-pituitary-adrenal (HPA) axis (5), an impairment of which has been linked to the development of anxiety and mood disorders (6). Further, this treatment has been reported to reduce DNA content (7), cell proliferation rate (8), synaptic density (9), and neurotrophic factor concentrations within the neonatal brain (10) and induces neural degeneration within the developing hippocampus (11). However, little is known about the consequences for later life, in particular, the effects on cognition-and anxiety-related behavior are unclear (5,12).The presynaptic marker protein synaptophysin is a calciumbinding protein that plays an important role in the generation and maintenance of small vesicle membranes and their interaction with cytoskeletal elements. Decrease in the synaptophysin IR is associated with brain injury and aging, possibly reflecting functional disturbances of synaptic transmission (13). The neuronal MAP2 determines stability and arrangement of neuronal microtubules. Loss of MAP2 IR after brain injury correlates with neuronal degeneration (14) and is associated with age-related impairment of synaptic plasticity, cognition, and memory functions. Interestingly, both synaptophysin IR and MAP2 IR have been reported ...